Kamada Ltd. (KMDA)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$8.07
+1.57%
Mkt Cap $448.86M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+86.0%
Consensus $15.00 vs current $8.07